INTRODUCTION
Stromal cells are involved in organogenic processes by controlling parenchymal cell functions such as migration, proliferation, differentiation and programmed cell death (1) .
Among stromal cells, macrophages (MPs) play a major role in maintenance of tissue homeostasis (2) . In addition to phagocytosis and antigen presentation, these cells play a supportive function in various tissues (2, 3) . However, MPs are renowned for their heterogeneity as reflected by the various specialized functions they adopt in different anatomical locations (2, 4) . Many of these activities appear to be opposing in nature: proinflammatory vs. anti-inflammatory, immunogenic vs. tolerogenic, and tissue-destructive vs. tissue repair activities (4) . Different activation states have been described in vitro for MPs, each being associated with a particular phenotype and function (2, 5) . Classical activation, obtained after LPS/IFNγ treatment, induces production of proinflammatory cytokines and reactive oxygen species.
Alternative activation, obtained after IL-4 treatment, increases expression of the mannose receptor (CD206). Deactivation by IL-10 and glucocorticoids induces production of IL-10, TGFβ1 and expression of the scavenger receptor CD163. However, it is not known to what extent these distinct activation states exist in vivo and whether MP fate is determined for ever or whether it remains constantly malleable (2) , although several in vitro studies have shown MP adaptation to changing microenvironment (4, (6) (7) (8) .
An additional degree of complexity is reached with the existence of several subsets of circulating monocytes. In both human and mouse, two main monocyte subsets are present in blood: the main CD14 hi CD16 -(CX3CR1 lo /Ly-6C hi in mouse) monocyte subset that invades tissues during acute inflammation, and the CD14 lo CD16 + (CX3CR1 hi /Ly-6C lo in mouse) monocyte subset, that is not -or in a less extent-recruited during inflammation (9) (10) (11) (12) (13) but is expanded in chronic diseases such as HIV infection, sepsis, tuberculosis or asthma (14) .
Both fate and function of this population remain unclear since, in mouse, it is present in HAL author manuscript inserm-00136917, version 1 HAL author manuscript inserm-00136917, version 1 HAL author manuscript inserm-00136917, version 1 normal spleen and may correspond to MPs residing in normal tissues (9) . However, there is growing evidence that they may result from maturation of Ly-6C hi monocytes (11, 15, 16) .
MPs are involved in skeletal muscle repair. Muscle damage induces massive MP infiltration at the injury site (17, 18) . Partial depletion of monocyte/MPs (MO/MPs) impairs muscle regeneration while reconstitution of bone marrow restores regeneration (19) (20) (21) (22) (23) .
Initially limited to phagocytosis of necrotic fibers, the pro-regenerative role of MPs was shown to involve a direct stromal support function (24, 25) . We have previously shown that monocyte-derived MPs enhance myogenic cell growth (26) . MPs release mitogenic growth factors for myogenic precursor cells (mpcs) and establish cell-cell interactions that protect mpcs from apoptosis (26, 27) . However, little is known about both MO/MP subsets and phenotypes at work during muscle regeneration. Studies in rat have shown that ED1+ MPs are associated with muscle necrosis, whereas ED2+ (CD163) MPs, regarded as "resident MPs", invade muscle once necrosis has been removed and are associated with regenerative myofibers (17, 28) . Although the nature of ED1 and ED2 MPs is not characterized, these results suggest that different MP subpopulations are associated with different stages of muscle repair.
In this study we used: in vivo tracing methods to analyze which monocyte subset was recruited after muscle injury; ex-vivo phenotyping analyses to characterize MO/MP profile during muscle regeneration; in vitro coculture experiments to identify which MP phenotype was associated with myogenesis; and sequential in vivo MO/MP depletion studies to evaluate the respective roles of both circulating and intramuscular MO/MPs in skeletal muscle repair.
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RESULTS

Two MO/MP subsets are sequentially present during muscle regeneration. MO/MPs
collected from skeletal muscle of CX3CR1 GFP/+ mouse (9, 15) were analyzed according to their GFP and Ly-6C expression during muscle regeneration. Normal muscle contained little CX3CR1 hi /Ly-6C -MO/MPs (about 200 cells/mg of muscle). Notexin was injected in tibialis anterior (TA) muscle to induce the necrosis/regeneration process. As soon as 90 min after injury, CX3CR1 lo /Ly-6C + MO/MPs were detected in muscle and rapidly invaded the tissue to reach a maximum point at 24 h post injury (25% of CD45 + cells). Then, CX3CR1 lo /Ly-6C + MO/MP population quickly declined with time while CX3CR1 hi /Ly-6C -MO/MPs appeared and continuously increased to reach a plateau at d 7 accounting for 35% of CD45 + cells extracted from muscle at this time point ( Fig. 1A) .
MO/MP percentage among CD45+ cells is a relative quantification that does not reflect the amount of MO/MPs actually present in muscle. Thus we calculated from these data the total number of extracted GFP + cells per mg of muscle. Results indicated that the extent of the two MO/MP waves was different ( Fig. 1B) , and this was confirmed by histological examination (Fig. 1C ). During the first 2 days, as injured myofibers became necrotic, 2000 to 3500 GFP + cells were counted per mg of muscle. At 4 and 7 days, when myogenic cells proliferated and further differentiated (Fig. 1C ), 5 to 6 fold more GFP + MO/MPs were found in muscle (12000 to 16000 cells per mg) ( Fig. 1B ). Ten days after injury, when centrally nucleated fibers were visible throughout the injured area (Fig. 1C ), the amount of GFP + cells had dramatically declined to reach less than 2000 GFP + cells per mg of tissue ( Fig. 1B) . 1B ). We analyzed proliferation of both subsets that were isolated from regenerating muscle by cell sorting ( Fig. 2A ). Ki67 labeling showed that Ly-6C + MO/MPs never proliferated whereas Ly-6C -MO/MPs partially entered into cell cycle from d 2, then the number of proliferating cells doubled at d 4 and further decreased by 2-fold at d 7 ( Fig. 2B ).
To compare the inflammatory profile of the two MO/MP populations, we analyzed cytokine expression of isolated Ly-6Cand Ly-6C + MO/MPs at d 4 post injury by RT-PCR.
Results showed that Ly-6C + MO/MPs expressed IL-1β and, to a lesser extent, TNFα transcripts more strongly than Ly-6C -MO/MPs (Fig. 2C ). Conversely, Ly-6C -MO/MPs expressed more strongly TGFβ1 and IL-10 than Ly-6C + MO/MPs (Fig. 2C ), indicating that Ly-6C + MO/MPs had an inflammatory profile and Ly-6C -MO/MPs had an anti-inflammatory profile.
Injured muscle only recruits CX3CR1 lo /Ly-6C + MO/MPs that subsequently switch
into anti-inflammatory CX3CR1 hi /Ly-6C -MO/MPs and differentiate into MPs. We labeled each circulating subset with fluorescent latex beads (LX) before injury, as previously described (12, 15) . Labeling of monocytes does not alter their migratory capacities (12) . After i.v. LX injection, circulating LX + cells were CX3CR1 hi /Ly-6Cmonocytes ( Fig RT-PCR analysis showed that Ly-6C + MO/MPs strongly expressed SLPI compared to Ly-6C -HAL author manuscript inserm-00136917, version 1 HAL author manuscript inserm-00136917, version 1 HAL author manuscript inserm-00136917, version 1
MO/MPs (62% increase of band intensity on 3 experiments) (Fig. 3B) 4 days after injury.
Inversely, PPARγ is expressed by MPs that down-regulate inflammation (33) (34) (35) . Our results showed that PPARγ mRNA was strongly expressed by Ly-6Ccompared to Ly-6C + MO/MPs (49% increase of band intensity on 3 experiments) ( Fig. 3B ).
Forward and side scatter of the two MO/MP subsets isolated at d 7 post injury showed that Ly-6C -MO/MPs had higher side scatter, and were larger than Ly-6C + MO/MPs (Fig. 3C ), in accordance with a maturation of the Ly-6Csubset. Analysis of differentiation markers showed that Ly-6C -MO/MPs expressed CD11c and higher levels of F4/80 ( Fig. 3C ). Nearly all (> 90%) F4/80 + cells were CD11c + and I-A b+ , and no positivity was observed for the dendritic cell marker DEC-205 (data not shown). These results show that on the contrary to Ly-6C + MO/MPs, Ly-6C -MO/MPs exhibited high levels of MP differentiation markers.
Altogether, these results suggest that after muscle injury, inflammatory Ly-6C + monocytes are recruited from blood, convert into anti-inflammatory Ly-6C -MO/MPs that proliferate in situ and further differentiate into mature MPs. increased their TGFβ1 secretion (P<0.03) ( Fig.4B ). We attempted to inhibit phagocytosis of proinflammatory MPs by colchicine (40) , cytochalasin D (41) and recombinant Annexin V (42) . Colchicine failed to inhibit phagocytosis and MPs changed their cytokine secretion upon mpc debris phagocytosis, as in untreated cells (Fig. 4C ). Conversely, phagocytosis was inhibited in the presence of cytochalasin D or recombinant Annexin V; in these conditions, TNFα and TGFβ1 secretion did not change in presence of mpc debris (Fig. 4C ). These data indicate that phagocytosis of mpc debris induced a switch of MP phenotype toward an antiinflammatory profile, as previously shown for other cell types (43) (44) (45) (46) .
Phagocytosis of muscle cell debris participates to
We also evaluated whether interactions with living mpcs may influence MP phenotype.
Neither addition of mpcs to previously activated MPs nor addition of mpcs prior to MP activation did significantly alter MP phenotype (data not shown). These data show that mpcs neither modified MP activation state nor prevented acquisition of any given MP phenotype.
Inflammatory MPs increase mpc growth whereas anti-inflammatory MPs stimulate their differentiation.
In coculture experiments we analyzed mpc behavior depending on MP activation state. We have previously shown that untreated MPs stimulate mpc growth and proliferation (26) . As shown in Fig After double DT injection both 12 h before and simultaneously to notexin injection (that induced a monocyte depletion lasting 0-24 h post injury), almost no MO/MP infiltration was observed ( Fig. 6E ). None of the hallmarks of regeneration were detected and persistence of necrotic fibers was observed until d 7 (Fig. 6E, Fig. 7 ), although circulating monocytes reappeared in the circulation from d 2 post injury (data not shown). When DT was injected 4 days after notexin, no difference was observed compared to control (Fig. 6B, Fig. 7 ), indicating that circulating monocytes were no longer recruited into muscle at this time.
Notably, i.v. injected DT did not significantly affect intramuscular MO/MPs, as shown by HAL author manuscript inserm-00136917, version 1 HAL author manuscript inserm-00136917, version 1 HAL author manuscript inserm-00136917, version 1 unchanged expression of both F4/80 and CD11b by CD45 + cells isolated from muscle ( Fig.   6F , insert).
We attempted to target intramuscular antiinflammatory MO/MPs, at a time when phagocytosis of necrotic myofibers is finished (Fig. 6B, Fig. 7A ). To assess MP depletion in muscle, flow cytometric analysis of CD45 + cells was performed 24 h after a single i.m. DT injection. The total number of F4/80 + cells present in muscle was diminished by 25% after DT injection, especially that of F4/80 hi cells, by 75% ( Fig. 8A ) (P<0.05), indicating that these differentiated FSC hi/ F4/80 hi MPs, corresponding to Ly-6C -MPs, were targeted by DT.
However, total number of CD45 + cells increased by 2 fold in DT vs. PBS injected muscle Consistently, histological examination 4-5 days later of whole TA muscle showed an area in which new cycles of regeneration were visible as assessed by the presence of necrotic and basophilic fibers ( Fig. 8B, arrow) . This area was restricted to the site of needle puncture, and was therefore excluded from the analysis to avoid counting of small regenerating myofibers coming from the secondary lesion ( Fig. 8B ). Diameter of centrally nucleated regenerating myofibers was evaluated in all the rest of TA and was found reduced by 41% in DT-vs. PBSinjected muscle (30.8 vs. 18.2 µm, respectively) ( Fig. 8C) (p<0.001) .
DISCUSSION
In the present study, we have shown that: i) injured skeletal muscle selectively recruits It has been shown that the CX3CR1 lo /Ly-6C + monocyte population is recruited in injured or inflamed tissues (9, 13, 48) . Our experiments using LX labeled circulating monocytes showed that CX3CR1 lo /Ly-6C + monocytes were selectively recruited rapidly after muscle injury. Mouse CX3CR1 lo /Ly-6C + monocytes and their human analogs bear several chemokine receptors, including CCR2, CCR1, CCR4, CCR7, CXCR1 and CXCR2 (9) . The corresponding chemokines are expressed by muscle tissue during the first days post injury (22, 49, 50) (cytokine expression profile is available at http://pepr.cnmcresearch.org). MCP-1 has been particularly involved in monocyte recruitment by injured muscle (19, 20) . We did not evidence recruitment of CX3CR1 hi /Ly-6Cmonocytes from blood to muscle. Moreover, 
MPs participate to both amplification of inflammation at time of injury and down-regulation
of the inflammatory response to avoid excess tissue damage (31, 53, 54) . MP stop-signals associated with resolution of inflammation include: i) induction of negative regulators of inflammation in MPs by environmental cues, and ii) non phlogistic phagocytosis. As shown herein, both likely operate during skeletal muscle regeneration. SLPI is considered as a brake on the response of MPs to inflammation (29, 31) . Its expression is induced by LPS and IL-6 and leads to inhibition of nitric oxide (NO) and TNFα production (30) . In vivo, the highest SLPI synthesis occurs during the proinflammatory phase and thus anticipates increase of TGFβ1 and IL-10 production (32). Accordingly, we have shown that CX3CR1 lo /Ly-6C + MO/MPs expressed more SLPI than CX3CR1 hi /Ly-6Ccells. Another marker associated with the resolution of inflammation by MPs is PPAR-γ. Fatty acids and prostaglandin metabolites bind to PPAR-γ in activated MPs, which triggers inhibition of both inducible NO synthase and release of proinflammatory cytokines (33, 35) , thus conferring anti-inflammatory properties to PPAR-γ (34) . Here we showed that antiinflammatory CX3CR1 hi /Ly-6C -MO/MPs strongly expressed PPAR-γ. Non phlogistic phagocytosis by MPs is another signal for switching to healing (31) . Binding and phagocytosis of apoptotic cells inhibit secretion of proinflammatory mediators and stimulate secretion of TGFβ1 and IL-10 by inflammatory MPs (43) (44) (45) (46) .
Induction of an anti-inflammatory process by phagocytosis of necrotic cells depends on the
cell type ingested (42, 43, 55) . We showed that both unstimulated and inflammatory MPs (59) . Almost all F4/80 + cells were also positive for CD11c and MHCII, as previously observed after inflammation in various organs (60, 61) , and were DEC-205 -. In the blood, Ly-6Cmonocytes, that come from Ly-6C + cells, are also CD11c + (12) . Therefore, appearance of CD11c + cells in the muscle may be a recapitulation of conversion from Ly-6C + /CD11cto Ly-6C -/CD11c + monocytes within the tissue. Thus, proliferating CX3CR1 hi /Ly-6C -MO/MPs and then differentiating CX3CR1 hi /Ly-6C -MPs are associated with the regenerative phase of muscle repair.
Depending on the context, MPs may have supportive or deleterious effects on cells: in chronic diseases, including those affecting skeletal muscle, MPs are deleterious (62, 63) while they support tissue repair in muscle and other various tissues including liver, brain, peripheral nerve and epithelium (19) (20) (21) (22) (64) (65) (66) (67) . If one except regulation of inflammation, studies documenting a direct role of MPs on cell behavior are scant and include intestinal HAL author manuscript inserm-00136917, version 1 progenitor proliferation (65) , erythroblast proliferation and maturation (68) , oligodendrocytic differentiation and myelination (69) . In vitro studies have shown that MP activation state may direct neural progenitor differentiation towards either neurogenesis or oligodendrogenesis (70) . Our results substantiate the view that MP function may be related to an activation state.
In coculture experiments, inflammatory MPs -the counterpart of inflammatory CX3CR1 lo /Ly-6C + cells observed in vivo-stimulated mpc proliferation and inhibited their differentiation.
Inversely, IL-4 treated and anti-inflammatory MPs exhibited a strong differentiating activity on mpc, assessed by both stimulation of myogenic program and increase of fusion into multinucleated cells. Molecular mechanisms involved in these processes are currently under investigation. It is likely that cytokines released by activated MPs influence myogenic cell behavior: TNFα is mitogenic for myoblasts and inhibits their differentiation (71, 72) ; IL-1β impairs myogenic differentiation through IGF-1 (73); in vitro effects of TGFβ1 are more controversial, although in vivo neutralization of TGFβ1 in regenerating muscle was shown to reduce the diameter of regenerating myofibers (74) . Beyond cytokines, COX2 and its metabolites may also play a role, as they were shown to be fusogenic and necessary for good muscle repair (75) (76) (77) . Previous in vivo studies using different injury models have shown that partial reduction of MO/MP entry into injured muscle hinders muscle regeneration, as shown by a delay in the appearance of regenerating myofibers and the persistence of intermuscular adipocytes (19) (20) (21) (22) . We observed similar features upon partial inhibition of monocyte recruitment in toxicinduced muscle regeneration. Moreover, when nearly no MO/MP was allowed to enter damaged muscle, myofibers remained in the necrotic state, pointing out the indispensable role of MPs in muscle repair. Interestingly, despite normalized level of circulating monocytes from d 2 post injury, no delayed recruitment was observed suggesting that signals governing monocyte recruitment are only transiently expressed by the damaged tissue, as it was recently documented in ultraviolet-injured skin (48) . Accordingly, depletion of circulating monocytes at d 4 post injury had no effect on muscle regeneration. On the other hand, HAL author manuscript inserm-00136917, version 1 HAL author manuscript inserm-00136917, version 1 HAL author manuscript inserm-00136917, version 1 depletion of intramuscular anti-inflammatory F4/80 hi MO/MPs at time of regeneration, i.e. once phagocytosis of necrotic myofibers is achieved, reduced the diameter of the centrally nucleated regenerating myofibers, indicating that these MO/MPs were involved in fiber growth, in accordance with our in vitro data.
In conclusion, our data evidence a phenotype transition operated by recruited MO/MPs during resolution of inflammation and tissue repair, that is associated to changes in their functions. We propose sequential involvements of these two phenotypically distinct MP populations during skeletal muscle repair as follows: within the first 24-48 h after injury, skeletal muscle recruits inflammatory circulating monocytes, that stimulate myogenic cell proliferation and prevent their differentiation. While they are exposed to inflammatory environment and operate phagocytosis of muscle cell debris, inflammatory MO/MPs convert into anti-inflammatory MO/MPs. As phagocytosis of necrotic myofibers is finished, these antiinflammatory MO/MPs actively proliferate and further differentiate into anti-inflammatory MPs, that sustain myogenic differentiation and myofiber growth, in addition to their protective effect on differentiating myotubes (27) and their effect on fiber membrane repair (78) .
MATERIALS AND METHODS
Animals. C57BL/6, CX3CR1 gfp/+ (9) and CD11b-DTR (47) mice were bred and used according to french legislation. Experiments were run at 4-8 weeks of age.
Muscle injury and muscle preparation. Notexin (10 µl, 25 µg/ml in PBS, Latoxan, Valence, France) was injected in the TA. For histological analysis, muscles were prepared as previously described (27) . Quantitative analysis of muscle regeneration was performed on the whole injured area: about 7 fields (x20 objective) were analyzed in each mouse, Labeling of blood monocytes. Labeling of circulating monocytes was performed exactly as described (15) with plain microspheres (Fluoresbrite polychromatic red 0.5-µm microspheres 2.5% solids; Polysciences Inc., Warrington, PA) and clo-lip, that were prepared as previously described (79) . Clodronate was a kind gift of Roche Diagnostics GmbH. Human mpc culture. Culture media components were from Invitrogen. Human mpcs were cultured from muscle samples as previously described (26) .
Depletion of circulating monocytes and intramuscular
Human MP cell culture. MPs were differentiated from monocytes isolated from human blood as previously described, at time of corrective surgery in conformity with french legislation (Code de la Santé Publique, livre II) (26 
